3rd Quarter - Report — ONCOLOGY NURSING SOCIETY for ONCOLOGY NURSING SOCIETY (2023)

Firm

ONCOLOGY NURSING SOCIETY

Client

ONCOLOGY NURSING SOCIETY

Income

—

Expenses

$47,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Palliative Care and Hospice Education and Training Act (PCHETA) (S.2243), Cancer Drug Parity Act (S.2039), Improving Care and Access to Nurses (H.R.2713/S. 2418), No Tax Subsidies for E-Cigarette and Tobacco Ads Act (S. 464/H.R. 4368), Safe Step Act (S. 652/H.R. 2630), National Triple-Negative Breast Cancer Day Resolution (H.R. 172), National Colorectal Cancer Awareness Month Resolution (H.R.213),Barbosa Act (S.302), Reducing Hereditary Cancer Act (S.765/H.R. 1526), National Cancer Prevention Day Resolution (H.R. 93), Colorectal Cancer Disparities Resolution (H.Res.224) Waiting for reintroduction: Improving Senior's Timely Access to Care Act,

Lobbyist	Covered position, as disclosed
ALEC STONE	Clinton White House, Women's Health Initiatives

Contacted: White House Office; SENATE; Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: S. 652 (118th), H.R. 213 (118th), S. 2039 (118th), H.R. 2713 (118th), S. 2418 (118th), S. 2243 (118th), H.R. 2630 (118th), H.Res. 224 (118th), H.R. 1526 (118th), H.R. 4368 (118th), H.R. 172 (118th), S. 765 (118th), H.R. 93 (118th), S. 302 (118th), S. 464 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.